Real-life efficacy and safety of idelalisib in 55 double-refractory follicular lymphoma patients.
Br J Haematol
; 199(3): 339-343, 2022 11.
Article
in En
| MEDLINE
| ID: mdl-36002151
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Lymphocytic, Chronic, B-Cell
/
Lymphoma, Follicular
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Journal:
Br J Haematol
Year:
2022
Document type:
Article